Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Amag Pharmaceuticals (AMAG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2000	09-2000	12-1999	09-1999	12-1998
Cash Flows From Operating Activities
Net Income	N/A	-11,264	N/A	-4,442	-2,610
Depreciation Amortization	100	554	130	802	200
Accounts receivable	N/A	9	N/A	339	N/A
Other Working Capital	-570	717	550	307	410
Other Operating Activity	2	6,396	0	-3,739	10
Operating Cash Flow	$-468	$-3,588	$680	$-6,734	$-1,990

Cash Flows From Investing Activities
Change In Deposits	N/A	2,690	N/A	9,014	N/A
PPE Investments	-2	-36	-3	-281	-170
Other Investing Activity	-8,880	-60	-1,740	7,422	-1,080
Investing Cash Flow	$-8,882	$2,594	$-1,743	$16,154	$-1,250

Cash Flows From Financing Activities
Common Stock Issued	N/A	62	N/A	8	N/A
Common Stock Repurchased	N/A	N/A	N/A	-80	N/A
Other Financing Activity	-60	0	0	0	10
Financing Cash Flow	$-60	$62	$N/A	$-73	$10

Beginning Cash Position	N/A	17,053	N/A	7,704	7,700
End Cash Position	N/A	16,121	N/A	17,053	4,440
Net Cash Flow	$-9,410	$-932	$-1,063	$9,348	$-3,250

Free Cash Flow
Operating Cash Flow	-468	-3,588	680	-6,734	-1,990
Capital Expenditure	N/A	-36	N/A	-281	N/A
Free Cash Flow	-468	-3,624	680	-7,014	-1,990